Residency · New Hyde Park, NY
Sponsored by Zucker School of Medicine at Hofstra/Northwell
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Journal of the American College of Cardiology · 2026 · 144 citations · Eugenia Gianos
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Lancet (London, England) · 2021 · 1,369 citations · Christos Fountzilas
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 1,081 citations · Christos Fountzilas
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation · 2026 · 103 citations · Eugenia Gianos
Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults.
The New England journal of medicine · 2023 · 267 citations · Micah Whitson
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
The New England journal of medicine · 2021 · 514 citations · Steven Nathan
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
JAMA oncology · 2023 · 399 citations · Jian Campian
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.
Lancet (London, England) · 2023 · 272 citations · Richard Lafayette